Choroidal Vascularity Index in CHM Carriers.

CHM CVI OCT carriers choroid choroideremia

Journal

Frontiers in ophthalmology
ISSN: 2674-0826
Titre abrégé: Front Ophthalmol (Lausanne)
Pays: Switzerland
ID NLM: 9918419176106676

Informations de publication

Date de publication:
2021
Historique:
received: 07 08 2021
accepted: 27 09 2021
medline: 20 10 2021
pubmed: 20 10 2021
entrez: 10 7 2024
Statut: epublish

Résumé

To assess the choroidal structure using the Choroidal Vascularity Index (CVI) and analyse choroidal changes in choroideremia (CHM) carriers. Female CHM carriers, genetically characterized, and a control group were recruited at the Eye Clinic of Careggi Teaching Hospital, Florence. The patients underwent a complete ophthalmic evaluation and retinal imaging. In particular, the Stromal Area (SA), Luminal Area (LA), Total Choroidal Area (TCA), CVI, and Subfoveal Choroidal Thickness (SFCT) were calculated for each eye using Optical Coherence Tomography (OCT) examinations. Twelve eyes of 6 CHM carriers and 14 eyes of 7 age-matched controls were analysed. The mean SFCT was 270.9 ± 54.3μm in carriers and 281.4 ± 36.8μm in controls (p = 0.564); LA was 0.99 ± 0.25mm The CVI and CVI-related parameters (SA, LA, and TCA) do not differ between CHM female carriers and controls. These findings reveal a preserved choroidal vasculature in eyes with RPE impairment and support the primary role of RPE in the pathogenesis of CHM disease.

Identifiants

pubmed: 38983966
doi: 10.3389/fopht.2021.755058
pmc: PMC11182189
doi:

Types de publication

Journal Article

Langues

eng

Pagination

755058

Informations de copyright

Copyright © 2021 Mucciolo, Giorgio, Lippera, Passerini, Pelo, Cipollini, Sodi, Virgili, Giansanti and Murro.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Auteurs

Dario Pasquale Mucciolo (DP)

Department of Neuroscience, Psychology, Drug Research and Child Health, University of Florence, Florence, Italy.
Ophthalmology Unit, San Jacopo Hospital, Pistoia, Italy.

Dario Giorgio (D)

Department of Neuroscience, Psychology, Drug Research and Child Health, University of Florence, Florence, Italy.

Myrta Lippera (M)

Department of Neuroscience, Psychology, Drug Research and Child Health, University of Florence, Florence, Italy.

Ilaria Passerini (I)

Department of Genetic Diagnosis, Careggi University Hospital, Florence, Italy.

Elisabetta Pelo (E)

Department of Genetic Diagnosis, Careggi University Hospital, Florence, Italy.

Francesca Cipollini (F)

Department of Neuroscience, Psychology, Drug Research and Child Health, University of Florence, Florence, Italy.

Andrea Sodi (A)

Department of Neuroscience, Psychology, Drug Research and Child Health, University of Florence, Florence, Italy.

Gianni Virgili (G)

Department of Neuroscience, Psychology, Drug Research and Child Health, University of Florence, Florence, Italy.
Fondazione GB Bietti, Rome, Italy.

Fabrizio Giansanti (F)

Department of Neuroscience, Psychology, Drug Research and Child Health, University of Florence, Florence, Italy.

Vittoria Murro (V)

Department of Neuroscience, Psychology, Drug Research and Child Health, University of Florence, Florence, Italy.

Classifications MeSH